Abbas Abbaszadegan1, Sahar Dadolahi2, Ahmad Gholami3, Mahmoud Reza Moein4, Shahram Hamedani5, Younes Ghasemi6, Paul Vincent Abbott7. 1. Department of Endodontics, School of Dentistry, Shiraz University of Medical Sciences, Fars, Islamic Republic of Iran. 2. Students' Research Committee, School of Dentistry International Branch, Shiraz University of Medical Sciences Fars, Islamic Republic of Iran. 3. Assistant Professor, Pharmaceutical Sciences Research Center and Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Fars, Islamic Republic of Iran, Phone: +989173140518, e-mail: gholami@sums.ac.ir. 4. Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Fars, Islamic Republic of Iran. 5. Private practice, Fars, Islamic Republic of Iran. 6. Pharmaceutical Sciences Research Center and Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Fars, Islamic Republic of Iran. 7. School of Dentistry, University of Western Australia, Australia.
Abstract
OBJECTIVE: The aim of this article was (i) to define the chemical constituents of Cinnamomum zeylanicum essential oil (CEO), (ii) to compare the antimicrobial activity of CEO with triple antibiotic paste (TAP) and calcium hydroxide [Ca(OH)2] on planktonic and biofilm Enterococcus faecalis; and (iii) to compare the cytotoxicity of these medicaments on L929 fibroblasts. MATERIALS AND METHODS: Gas chromatography-mass spectrometry was used to define the constituents of CEO. Zone of inhibition, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and time-kill tests were performed. Further, 108 human teeth were infected with E. faecalis and treated with the medicaments for 1, 7, and 14 days. Cytotoxicity was assessed by exposing L929 fibroblasts to the medicaments. RESULTS: Cinnamaldehyde was the main component of CEO. Triple antibiotic paste had the greatest zone of inhibition and the smallest MIC and MBC. Triple antibiotic paste and CEO eradicated planktonic E. faecalis after 4 and 24 hours, while Ca(OH)2 failed to achieve 100% killing after 24 hours. Cinnamomum zeylanicum essential oil and TAP eradicated biofilm E. faecalis after 7 and 14 days, but Ca(OH)2 could not eliminate E. faecalis after 14 days. Cinnamomum zeylanicum essential oil was the most biocompatible medicament. CONCLUSION: Cinnamomum zeylanicum essential oil is an efficient antibacterial agent against planktonic and biofilm E. faecalis and it was cytocompatible to L929 fibroblasts. Therefore, CEO has the potential to be used as an antimicrobial agent in root canal treatment.
OBJECTIVE: The aim of this article was (i) to define the chemical constituents of Cinnamomum zeylanicum essential oil (CEO), (ii) to compare the antimicrobial activity of CEO with triple antibiotic paste (TAP) and calcium hydroxide [Ca(OH)2] on planktonic and biofilm Enterococcus faecalis; and (iii) to compare the cytotoxicity of these medicaments on L929 fibroblasts. MATERIALS AND METHODS: Gas chromatography-mass spectrometry was used to define the constituents of CEO. Zone of inhibition, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and time-kill tests were performed. Further, 108 human teeth were infected with E. faecalis and treated with the medicaments for 1, 7, and 14 days. Cytotoxicity was assessed by exposing L929 fibroblasts to the medicaments. RESULTS:Cinnamaldehyde was the main component of CEO. Triple antibiotic paste had the greatest zone of inhibition and the smallest MIC and MBC. Triple antibiotic paste and CEO eradicated planktonic E. faecalis after 4 and 24 hours, while Ca(OH)2 failed to achieve 100% killing after 24 hours. Cinnamomum zeylanicum essential oil and TAP eradicated biofilm E. faecalis after 7 and 14 days, but Ca(OH)2 could not eliminate E. faecalis after 14 days. Cinnamomum zeylanicum essential oil was the most biocompatible medicament. CONCLUSION:Cinnamomum zeylanicum essential oil is an efficient antibacterial agent against planktonic and biofilm E. faecalis and it was cytocompatible to L929 fibroblasts. Therefore, CEO has the potential to be used as an antimicrobial agent in root canal treatment.
Authors: Thiago A F Ferro; Jéssica M M Araújo; Bruna L Dos Santos Pinto; Jéssica S Dos Santos; Eliene B Souza; Bruna L R da Silva; Valderlane L P Colares; Tânia M G Novais; Clovis M B Filho; Carsten Struve; João B Calixto; Valério Monteiro-Neto; Luís C N da Silva; Elizabeth S Fernandes Journal: Front Microbiol Date: 2016-12-21 Impact factor: 5.640
Authors: Marianne de Lucena Rangel; Sabrina Garcia de Aquino; Jefferson Muniz de Lima; Lúcio Roberto Castellano; Ricardo Dias de Castro Journal: Evid Based Complement Alternat Med Date: 2018-10-17 Impact factor: 2.629